Lantern Pharma Inc. (LTRN) Operating income 2021–2025
Lantern Pharma Inc. (LTRN) annual operating income history from SEC filings — each fiscal year as reported.
-$18.0MFY2025 · since FY2021: -$12.6M → -$18.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.0M | +19.1% |
| FY2024 | -$22.2M | -24.3% |
| FY2023 | -$17.9M | -23.9% |
| FY2022 | -$14.4M | -14.6% |
| FY2021 | -$12.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice